These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33760215)

  • 21. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
    Liu S; Ge X; Su L; Zhang A; Mou X
    Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC).
    Wang Y; Wu Y; Xie S
    Bioengineered; 2022 Feb; 13(2):3651-3664. PubMed ID: 35230201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
    Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
    J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
    Li K; Yuan C
    Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
    Li GJ; Zhao GQ; Yang JP; Zhou YC; Yang KY; Lei YJ; Huang YC
    Oncol Rep; 2017 Jun; 37(6):3475-3483. PubMed ID: 28498474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
    Wu X; Li X; Xu G
    Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Tang Q; Li M; Chen L; Bi F; Xia H
    Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.
    Xu YH; Tu JR; Zhao TT; Xie SG; Tang SB
    Int J Oncol; 2019 Jan; 54(1):295-305. PubMed ID: 30431074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA‑671‑5p inhibits cell proliferation, migration and invasion in non‑small cell lung cancer by targeting MFAP3L.
    Ye J; Luo W; Luo L; Zhai L; Huang P
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34841435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA CBR3 antisense RNA 1 promotes the aggressive phenotypes of non‑small‑cell lung cancer by sponging microRNA‑509‑3p and competitively upregulating HDAC9 expression.
    Guan Y; Yang J; Liu X; Chu L
    Oncol Rep; 2020 Oct; 44(4):1403-1414. PubMed ID: 32945466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
    Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
    Tan X; Jiang L; Wu X; Feng W; Lin Q
    Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y; Song T; Shi Z; Li W; Yang S; Li D
    Gene; 2021 Feb; 768():145309. PubMed ID: 33197518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN.
    Li Y; Li L; Guan Y; Liu X; Meng Q; Guo Q
    Biochem Biophys Res Commun; 2013 Nov; 440(4):604-10. PubMed ID: 24099768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
    Jiao P; Hou J; Yao M; Wu J; Ren G
    Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.
    Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
    Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.